Skip to main content
SpringerLink
Log in
Book cover

Pharmakotherapie pp 367–388Cite as

Rheumatische Erkrankungen

  • Chapter

  • 279 Accesses

Part of the book series: Springer-Lehrbuch ((SLB))

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Weiterführende Literatur

  • Arend SM, Breedveld FC, van Dissel JT (2003) TNF-alpha blockade and tuberculosis: better look before you leap. Neth J Med 61(4): 111–9

    PubMed  CAS  Google Scholar 

  • Bacon PA, Stevens RJ, Carruthers DM, Young SP, Kitas GD (2002) Accelerated atherogenesis in autoimmune rheumatic diseases. Autoimmun Rev 1(6): 338–47

    Article  PubMed  CAS  Google Scholar 

  • Brewer, EJ, Giannini EH, Kuzmina N, Alekseev L (1986) Penicillamine and hydroxychloroquine in the treatment of severe juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind placebo-controlled trial. N. Engl. J. Med. 314: 1269

    Article  PubMed  CAS  Google Scholar 

  • Brune K, Kalden J, Zacher J Zeilhofer HU (2000) Selektive Inhibitoren der Cyclooxygenase 2: Evolution oder Revolution? Deutsches Ärzteblatt 97: A 1818–1825

    Google Scholar 

  • Brune K, Zeilhofer HU (1999) Handbook of Pain. Antipyretic (non-narcotic) analgesics. Textbook of Pain, Churchill Livingstone, Edinborough, 1139–1154

    Google Scholar 

  • Clark P, Casas E, Tugwell P, Medina C, Gheno C, Tenorio G, Orozco JA (1993) Hydroxychloroquine compared with placebo in rheumatoid arthritis. A randomized controlled trial. Ann. Intern. Med. 119: 1067

    PubMed  CAS  Google Scholar 

  • Creamer P, Hochberg M (1997) Osteoarthritis. Lancet 350: 503–508

    Article  PubMed  CAS  Google Scholar 

  • Den Broedder AA, Assmann KJ, van Riel PL, Wetzels JF (2003) Nephrotic syndrome as a complication of anti-TNFα in a patient with rheumatoid arthritis. Neth J Med 61(4): 137–41

    Google Scholar 

  • Deutsche Gesellschaft für Rheumatologie. Stellungnahme der Deutschen Gesellschaft für Rheumatologie (Kommission Pharmakotherapie) zur Anwendung spezifischer Cox-2-Inhibitoren bei rheumatischen Erkrankungen (Stand August 2001). 527–530

    Google Scholar 

  • Domljan Z, Vrhovac B, Durrigl T, Pucar I (1989) A double-blind trial of ademetionine vs naproxen in activated gonarthrosis. Int. J. Clin. Pharmacol. Ther. Toxicol. 27: 329

    PubMed  CAS  Google Scholar 

  • Giannini EH, Brewer EJ, Kuzmina N et al. (1992) Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebocontrolled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children’s Study Group. N Engl J Med 326: 1043

    Article  PubMed  CAS  Google Scholar 

  • Graninger W, Smolen J (2002) Treatment of rheumatoid arthritis by TNF-blocking agents. Int Arch Allergy Immunol 127(1): 10–4

    Article  PubMed  CAS  Google Scholar 

  • Gremillion RB, Posever JO, Manek N, West JP, van Volen-Hoven RF (1999) Tacrolimus (FK506) in the treatment of severe, refractory rheumatoid arthritis. Initial experience in 12 patients. J. Rheumatol. 26: 2332

    PubMed  CAS  Google Scholar 

  • Huskisson EC, Donnelly S (1999) Hyaluronic acid in the treatment of osteoarthritis of the knee. Rheumatology 38: 602

    Article  PubMed  CAS  Google Scholar 

  • Jessop JD, O’Sullivan MM, Lewis PA, Williams LA, Camilleri JP, Plant MJ, Coles EC (1998) A long-term five-year randomized controlled trial of hydroxychloroquine, sodium aurothiomalate, auranofin and penicillamine in the treatment of patients with rheumatoid arthritis. Br. J. Rheumatol. 37: 992

    Article  PubMed  CAS  Google Scholar 

  • Jeurissen ME, Boerbooms AM, van de Putte LB et al. (1991) Methotrexate versus azathioprine in the treatment of rheumatoid arthritis. A forty-eight-week randomized, double-blind trial. Arthritis Rheum. 34: 961

    PubMed  CAS  Google Scholar 

  • Kary S, Burmester G (2003) Anakinra: the first interleukin-1 inhibitor in the treatment of rheumatoid arthritis. Int J Clin pract 57(3): 231–4.

    PubMed  CAS  Google Scholar 

  • Kvien TK, Hoyeraal HM, Sandstad B (1986) Azathioprine versus placebo in patients with juvenile rheumatoid arthritis. A single center double blind comparative study. J. Rheumatol. 13: 118

    PubMed  CAS  Google Scholar 

  • Maini RN, Breedveld FC, Kalden JR et al. (1998) Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum. 41: 1552

    Article  PubMed  CAS  Google Scholar 

  • Manger B (2002) Empfehlungen der Deutschen Gesellschaft für Rheumatologie zur Therapie der rheumatoiden Arthritis mit dem Interleukin-1-Rezeptor Antagonisten Anakinra. Z Rheumatol 61(1): 698–700

    Article  PubMed  CAS  Google Scholar 

  • Manger B (2002) Revised recommendations of the Deutsche Gesellschaft für Rheumatologie on therapy with tumor necrosis factor-inhibiting active substances on inflammatory diseases. Z Rheumatol 61(6):694–7

    Article  PubMed  CAS  Google Scholar 

  • McAlindon TE, LaValley MP, Gulin JP, Felson DT (2000) Glucosamine and chondroitin for treatment of osteoarthritits. A systematic quality assessment and meta-analysis. JAMA 283: 1469

    Article  PubMed  CAS  Google Scholar 

  • Moreland LW, Schiff MH, Baumgartner SW et al. (1999) Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial. Ann. Intern. Med. 130: 478

    PubMed  CAS  Google Scholar 

  • Simon LS, Smolen JS, Abramson SB et al. (2002) Controversies in COX-2 selective inhibitors. J Rheumatol 29(7): 1501–10

    PubMed  CAS  Google Scholar 

  • Smolen JS, Kalden JR, Scott DL et al. (1999) Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis. A double-blind, randomised, multicentre trial. European Leflunomide Study Group. Lancet, 353: 259

    Article  PubMed  CAS  Google Scholar 

  • Strand V, Cohen S, Schiff M et al. (1999) Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group. Arch. Intern. Med. 159: 2542

    Article  PubMed  CAS  Google Scholar 

  • Tugwell P, Pincus T, Yocum D et al. (1995) Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. The Methotrexate-Cyclosporine Combination Study Group. N. Engl. J. Med. 333: 137

    Article  PubMed  CAS  Google Scholar 

  • Van Rossum MA, Fiselier TJ, Franssen MJ et al. (1998) Sulfasalazine in the treatment of juvenile chronic arthritis. A randomized, double-blind, placebo-controlled, multicenter study. Dutch Juvenile Chronic Arthritis Study Group. Arthritis Rheum. 41: 808

    Article  PubMed  Google Scholar 

  • Verstappen SM, Jacobs JW, Bijlsma JW, Heurkens AH, van Booma-Frankfort C, Borg EJ, Hofman DM, van der Veen MJ (2003) Five-year follow-up of rheumatoid arthritis patients after early treatment with disease-modifying antirheumatic drugs versus treatment according to the pyramid approach in the first year. Arthritis Rheum, 48(7): 1797–807

    Article  PubMed  Google Scholar 

  • Weinblatt ME, Coblyn JS, Fox DA, Fraser PA, Holdsworth DE, Glass DN, Trentham DE (1985) Efficacy of low-dose methotrexate in rheumatoid arthritis. N. Engl. J. Med. 312: 818

    Article  PubMed  CAS  Google Scholar 

  • Weinblatt ME, Kaplan H, Germain BF et al. (1994) Methotrexate in rheumatoid arthritis. A five-year prospective multicenter study. Arthritis Rheum. 37: 1492

    PubMed  CAS  Google Scholar 

  • Weinblatt ME, Kremer JM, Bankhurst AD et al. (1999) A trial of etanercept, a recombinant tumor necrosis factor receptor. Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N. Engl. J. Med. 340: 253

    Article  PubMed  CAS  Google Scholar 

  • Weinblatt ME, Kaplan H, Germain BF et al. (1990) Low-dose methotrexate compared with auranofin in adult rheumatoid arthritis. A thirty-six-week, double-blind trial. Arthritis Rheum. 33: 330

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Experimentelle und Klinische Pharmakologie und Toxikologie, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsstraße 22, 91054, Erlangen

    Professor Dr. med. Dr. h.c. K. Brune

  2. Medizinische Klinik III mit Poliklinik, Friedrich-Alexander-Universität Erlangen-Nürnberg, Krankenhausstraße 12, 91054, Erlangen

    Prof. Dr. med. B. Manger

Authors
  1. Professor Dr. med. Dr. h.c. K. Brune
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. med. B. Manger
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Heidelberg

About this chapter

Cite this chapter

Brune, K., Manger, B. (2004). Rheumatische Erkrankungen. In: Pharmakotherapie. Springer-Lehrbuch. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-35149-3_22

Download citation

  • DOI: https://doi.org/10.1007/3-540-35149-3_22

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-20414-5

  • Online ISBN: 978-3-540-35149-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation